Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

被引：99
|
作者：
Ghaffari, Maryam [1 ,2 ,3 ]
Dehghan, Gholamreza [2 ]
Baradaran, Behzad [4 ]
Zarebkohan, Amir [5 ]
Mansoori, Behzad [4 ]
Soleymani, Jafar [6 ]
Dolatabadi, Jafar Ezzati Nazhad [7 ]
Hamblin, Michael R. [8 ,9 ,10 ]
机构：
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[7] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[8] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA
[10] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa
来源：
COLLOIDS AND SURFACES B-BIOINTERFACES | 2020年 / 188卷
关键词：
Curcumin; Bcl-2; siRNA; PAMAM dendrimer; Co-delivery; HeLa cancer cells; Nanoparticles; DENDROSOMAL CURCUMIN; ANTICANCER ACTIVITY; INDUCE APOPTOSIS; BREAST-CANCER; IN-VITRO; NANOPARTICLES; DRUG; DOXORUBICIN; CISPLATIN; PATHWAYS;
D O I：
10.1016/j.colsurfb.2019.110762
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Co-delivery of therapeutic agents and small interfering RNA (siRNA) can be achieved by a suitable nanovehicle. In this work, the solubility and bioavailability of curcumin (Cur) were enhanced by entrapment in a poly-amidoamine (PAMAM) dendrimer, and a polyplex was formed by grafting Bcl-2 siRNA onto the surface amine groups to produce PAMAM-Cur/Bcl-2 siRNA nanoparticles (NPs). The synthesized polyplex NPs had a particle size of similar to 180 nm, and high Cur loading content of similar to 82 wt%. Moreover, the PAMAM-Cur/Bcl-2 siRNA NPs showed more effective cellular uptake, and higher inhibition of tumor cell proliferation compared to PAMAM-Cur nanoformulation and free Cur, due to the combined effect of co-delivery of Cur and Bcl-2 siRNA. The newly described PAMAM-Cur/Bcl-2 siRNA polyplex NPs could be a promising co-delivery nanovehicle.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance
    Yu, Miao
    Han, Shangcong
    Kou, Zhongai
    Dai, Jialing
    Liu, Jiao
    Wei, Chen
    Li, Yitong
    Jiang, Lutao
    Sun, Yong
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (02) : 323 - 332
  • [32] Co-delivery of gambogenic acid and VEGF-siRNA with anionic liposome and polyethylenimine complexes to HepG2 cells
    Yu, Qiongfang
    Zhang, Bian
    Zhou, Yali
    Ge, Qin
    Chang, Jiali
    Chen, Yunna
    Zhang, Kaiqi
    Peng, Daiyin
    Chen, Weidong
    JOURNAL OF LIPOSOME RESEARCH, 2019, 29 (04) : 322 - 331
  • [33] Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines
    Da Silva, C. G.
    Camps, M. G. M.
    Li, T. M. W. Y.
    Chan, A. B.
    Ossendorp, F.
    Cruz, L. J.
    BIOMATERIALS, 2019, 220
  • [34] Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
    Yoon, Hong Yeol
    Son, Sejin
    Lee, So Jin
    You, Dong Gil
    Yhee, Ji Young
    Park, Jae Hyung
    Swierczewska, Maggie
    Lee, Seulki
    Kwon, Ick Chan
    Kim, Sun Hwa
    Kim, Kwangmeyung
    Pomper, Martin G.
    SCIENTIFIC REPORTS, 2014, 4
  • [35] Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
    Tian, Guixiang
    Pan, Ruiyan
    Zhang, Bo
    Qu, Meihua
    Lian, Bo
    Jiang, Hong
    Gao, Zhiqin
    Wu, Jingliang
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [36] Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin. and Bcl-2 siRNA in breast cancer therapy
    Qian, Junmin
    Xu, Minghui
    Suo, Aili
    Xu, Weijun
    Liu, Ting
    Liu, Xuefeng
    Yao, Yu
    Wang, Hongjie
    ACTA BIOMATERIALIA, 2015, 15 : 102 - 116
  • [37] Targeted delivery of Bcl-2 conversion gene by MPEG-PCL-PEI-FA cationic copolymer to combat therapeutic resistant cancer
    Li, Zibiao
    Liu, Xuan
    Chen, Xiaohong
    Chua, Ming Xuan
    Wu, Yun-Long
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 76 : 66 - 72
  • [38] Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating
    Jagani, Hitesh Vitthalbhai
    Josyula, Venkata Rao
    Palanimuthu, Vasanth Raj
    Hariharapura, Raghu Chandrashekar
    Gang, Sagar Shantimal
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (4-5) : 611 - 618
  • [39] Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes
    Anup Jose
    Suman Labala
    Kunal Manoj Ninave
    Sudeep Kumar Gade
    Venkata Vamsi Krishna Venuganti
    AAPS PharmSciTech, 2018, 19 : 166 - 175
  • [40] A pH-responsive metal-organic framework for the co-delivery of HIF-2α siRNA and curcumin for enhanced therapy of osteoarthritis
    Zhang, Zi-Jian
    Hou, Ying-Ke
    Chen, Ming-Wa
    Yu, Xue-Zhao
    Chen, Si-Yu
    Yue, Ya-Ru
    Guo, Xiong-Tian
    Chen, Jin-Xiang
    Zhou, Quan
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
12345